Volume 1 - Issue 1, November-December 2007 - Exhibitors @ RSNA 2010

Medtronic Announces European Introduction of Cardiac Monitor

Medtronic has announced the European introduction of Reveal® XT, the first Insertable Cardiac Monitor that offers longterm and continuous monitoring of Atrial Fibrillation (AF). All other current monitoring tools are either for a limited period or on an intermittent basis. Longterm, continuous monitoring means that a clinician no longer needs to rely only on incomplete data to evaluate how AF may be progressing or treatment effectiveness. The device recently received the CE (Conformité Européenne) Mark, and the first implant of Reveal XT took place at Asklepios Klinik St. Georg in Hamburg, Germany by Prof. Karl- Heinz Kuck, M.D. The Reveal XT insertable cardiac monitor is not currently available for sale in the United States.

Print as PDF
Medtronic has announced the European introduction of Reveal® XT, the first Insertable Cardiac Monitor that offers longterm and continuous monitoring of Atr

No comment


Please login to leave a comment...